Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jost

Showing results (181-190 of 202) with videos related to

Pageof 21
Sort By:
European Journal of Haematology|November 24, 2019
Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesisVeronika Dill, Johanna Kauschinger, Richard T Hauch, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2022
Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation TherapyAngelika Terbuch, Florian Posch, Thomas Bauernhofer, et al.
Nature Communications|September 28, 2021
In vivo inducible reverse genetics in patients' tumors to identify individual therapeutic targetsMichela Carlet, Kerstin Völse, Jenny Vergalli, et al.
Science Signaling|January 17, 2023
Tyrosine kinase inhibitors can activate the NLRP3 inflammasome in myeloid cells through lysosomal damage and cell lysisEmilia Neuwirt, Giovanni Magnani, Tamara Ćiković, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 8, 2018
Effect of ABCG2, OCT1, and ABCB1 (MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI SubtrialSébastien Rinaldetti, Markus Pfirrmann, Kirsi Manz, et al.
Nature|November 26, 2020
Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasmsAshok Kumar Jayavelu, Tina M Schnöder, Florian Perner, et al.
Cell Death & Disease|October 18, 2020
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancerAnna-Lena Scherr, Andreas Mock, Georg Gdynia, et al.
Journal of Hepatology|June 30, 2020
Reduced mitochondrial resilience enables non-canonical induction of apoptosis after TNF receptor signaling in virus-infected hepatocytesSandra Lampl, Marianne K Janas, Sainitin Donakonda, et al.
Science Immunology|November 5, 2021
XIAP restrains TNF-driven intestinal inflammation and dysbiosis by promoting innate immune responses of Paneth and dendritic cellsAdam Wahida, Madeleine Müller, Andreas Hiergeist, et al.
Science Translational Medicine|November 26, 2025
Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in miceUlrike Höckendorf, Sayantanee Dutta, Arnold Kloos, et al.
Pageof 21

Showing results (181-190 of 202) with videos related to

Sort By:
Pageof 21
European Journal of Haematology|November 24, 2019
Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesisVeronika Dill, Johanna Kauschinger, Richard T Hauch, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2022
Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation TherapyAngelika Terbuch, Florian Posch, Thomas Bauernhofer, et al.
Nature Communications|September 28, 2021
In vivo inducible reverse genetics in patients' tumors to identify individual therapeutic targetsMichela Carlet, Kerstin Völse, Jenny Vergalli, et al.
Science Signaling|January 17, 2023
Tyrosine kinase inhibitors can activate the NLRP3 inflammasome in myeloid cells through lysosomal damage and cell lysisEmilia Neuwirt, Giovanni Magnani, Tamara Ćiković, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 8, 2018
Effect of ABCG2, OCT1, and ABCB1 (MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI SubtrialSébastien Rinaldetti, Markus Pfirrmann, Kirsi Manz, et al.
Nature|November 26, 2020
Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasmsAshok Kumar Jayavelu, Tina M Schnöder, Florian Perner, et al.
Cell Death & Disease|October 18, 2020
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancerAnna-Lena Scherr, Andreas Mock, Georg Gdynia, et al.
Journal of Hepatology|June 30, 2020
Reduced mitochondrial resilience enables non-canonical induction of apoptosis after TNF receptor signaling in virus-infected hepatocytesSandra Lampl, Marianne K Janas, Sainitin Donakonda, et al.
Science Immunology|November 5, 2021
XIAP restrains TNF-driven intestinal inflammation and dysbiosis by promoting innate immune responses of Paneth and dendritic cellsAdam Wahida, Madeleine Müller, Andreas Hiergeist, et al.
Science Translational Medicine|November 26, 2025
Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in miceUlrike Höckendorf, Sayantanee Dutta, Arnold Kloos, et al.
Pageof 21